COMMUNIQUE DE PRESSE
COMMUNIQUE DE PRESSE: NACON LANCE UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PRÉFÉRENTIEL DE SOUSCRIPTION
July 03, 2024 01:30 ET | NACON
NACON                                                 LE PRESENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ DIRECTEMENT OU INDIRECTEMENT AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA OU AU...
PRESS RELEASE: NACON
PRESS RELEASE: NACON LAUNCHES RIGHTS ISSUE WITH PRE-EMPTIVE RIGHTS
July 03, 2024 01:30 ET | NACON
NACON                                                 THIS PRESS RELEASE MUST NOT BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. THIS...
Apparel-group-logo.png
Apparel Group Launches Exciting ‘Summer-Time’ Campaign 2024 Featuring More than 36 of Their Brands
July 03, 2024 01:22 ET | The Apparel Group
Apparel Group hosted a lifestyle shoot in partnership with Anantara The Palm Resort, showcasing their summer collections that are available in store and on 6thstreet.com.Celebrating Summer Time with...
Regeneron Logo.jpg
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
July 03, 2024 01:00 ET | Regeneron Pharmaceuticals, Inc.
First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved...
sphericalinsightsoptionblue.png
Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29%
July 03, 2024 01:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , July 03, 2024 (GLOBE NEWSWIRE) -- The Global Allergy Therapeutics Market Size is to Grow from USD 23.1 Billion in 2023 to USD 42.5 Billion by 2033, at a Compound Annual...
Sanofi new_logo.jpg
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
July 03, 2024 01:00 ET | Sanofi - Aventis Groupe
Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two...
Start of Day Message
July 03, 2024 01:00 ET | GlobeNewswire, Inc.
LONDON, 03 Jul. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Yantai Exhibition Celebrates 27th Anniversary of Hong Kong's Return to Motherland HONG KONG, July 03, 2024 (GLOBE NEWSWIRE) -- On June 29, the celebration of the 27th Anniversary of Hong Kong's return to the motherland, organized by the Hong Kong Celebrations Association, was...
OKX logo-black.png
OKX Wallet Now Integrated with Ref Finance, a DeFi Platform Built on NEAR
July 02, 2024 23:48 ET | OKX
SINGAPORE, July 03, 2024 (GLOBE NEWSWIRE) -- OKX, a leading Web3 technology company, has issued updates for July 3, 2024. OKX Wallet Now Integrated with Ref Finance, a DeFi Platform Built on NEAR ...
OKX logo-black.png
OKX Wallet Now Integrated with LiNEAR Protocol, an Omni-Chain Liquid Restaking Solution Built on NEAR
July 02, 2024 23:31 ET | OKX
SINGAPORE, July 02, 2024 (GLOBE NEWSWIRE) -- OKX, a leading Web3 technology company, has issued updates for July 3, 2024. OKX Wallet Now Integrated with LiNEAR Protocol, an Omni-Chain Liquid...